Clinical Trials Logo
  1. Home
  2. Post Partum Hemorrhage
  3. NCT05298826
  4. Details
NCT05298826 Clinical Trial

Recombinant Factor VII for Intractable Postpartum Haemorrhage

Post Partum Hemorrhage Clinical Trial

Official title:
Recombinant Factor VII for the Conservative Management Trials of Intractable Postpartum Haemorrhage: is it a Drug Effect , Operator Experience or Inherent Result of the Aetiology.

Clinical Trial Details — Status: Completed

Administrative data
NCT number NCT05298826
Other study ID # Recombinant factor VII
Secondary ID
Status Completed
Phase
First received
Last updated
Start date June 1, 2019
Est. completion date January 10, 2020

Study information
Verified date March 2022
Source Aljazeera Hospital
Contact n/a
Is FDA regulated No
Health authority
Study type Observational

Clinical Trial Summary

Postpartum haemorrhage remains at the top of the causes of maternal deaths in both developed and developing countries .

Description:

Major postpartum haemorrhage is a dangerous complication that accounts for the highest maternal morbidity rate

Recruitment information / eligibility
Status Completed
Enrollment 41
Est. completion date January 10, 2020
Est. primary completion date January 1, 2020
Accepts healthy volunteers No
Gender Female
Age group 18 Years to 45 Years
Eligibility Inclusion Criteria: - Women with severe resistant postpartum hemorage Exclusion Criteria: - women without postpartum hemorage

Study Design

Related Conditions & MeSH terms

Intervention

Drug:
• recombinant factor VIIa
using recombinant factor VIIa

Locations
Country Name City State
Egypt Doaaa Alaa Cairo

Sponsors (1)
Lead Sponsor Collaborator
Aljazeera Hospital

Country where clinical trial is conducted

Egypt, 

Outcome
Type Measure Description Time frame Safety issue
Primary The number of women who had hysterectomy number of women resistant to the treatment and needed hysterectomy 24 hours
See also
  Status Clinical Trial Phase
Completed NCT03680339 - The Effect of Preoperative and Post Operative Misoprostol Administration on Intraoperative Blood Loss and Postpartum Hemorrhage in CS Phase 4
Completed NCT03693599 - Carbetocin Versus Syntometrine in Obese Women Undergoing Elective Cesarean Phase 4
Completed NCT03707132 - Tourniquet Reduces Blood Loss in Postpartum Hemorrhage During Hysterectomy for Placenta Accreta
Recruiting NCT02306733 - Ergometrine Versus Oxytocin in the Management of Atonic Post-partum Haemorrhage (PPH) in Women Delivered Vaginally Phase 3
Completed NCT01866241 - Combating Maternal Mortality in Uganda: An Assessment of the Role of Misoprostol in Prevention of Post-Partum Hemorrhage Phase 3
Not yet recruiting NCT01236482 - Oxytocin in Cesarean Delivery Phase 4
Completed NCT03784794 - Patient Blood Management for Massive Obstetric Hemorrhage N/A
Enrolling by invitation NCT06255496 - QStat Cartridge in Obstetric Patients
Recruiting NCT04401839 - Amr Maneuver for Prevention of Postpartum Hemorrhage N/A
Recruiting NCT06219538 - DAISY Uterine Drain Device Evaluation N/A
Not yet recruiting NCT06333340 - Comparative Efficacy of Carbetocin and Oxytocin in Parturients at Risk of Atonic Postpartum Hemorrhage Undergoing Elective Cesarean Delivery N/A
Completed NCT01863706 - Misoprostol Versus Oxytocin for Prevention of Post Partum Hemorrhage Phase 1
Terminated NCT04277962 - Estimating Blood Loss Using TritonTM in Vaginal Deliveries: A Validation Trial N/A
Completed NCT04723979 - NovoSeven® in Severe Postpartum Haemorrhage - Experiences From UK, DK, FR, NL
Completed NCT03570723 - Glove-loaded Foley's Catheter Tamponade for Cesarean Section for Placenta Previa N/A
Completed NCT03117647 - Mansoura-VV Uterine Compression Suture for Primary Atonic Postpartum Hemorrhage N/A
Active, not recruiting NCT03069859 - Use of TXA to Prevent Postpartum Hemorrhage Phase 2
Not yet recruiting NCT03891082 - A Comparative Study Between Bakri Balloon and B Lynch Suture Used to Control Primary Postpartum Hemorrhage After Cesarean Section N/A
Not yet recruiting NCT03463070 - Misoprostol Before and After Cesarean Section Phase 3
Recruiting NCT05532215 - Sublingual Misoprostol in Reduction of Caesarean Blood Loss N/A